AstraZeneca Prices $6B Bond To Help Fund ZS Pharma Buy
Drugmaker AstraZeneca PLC priced a $6 billion bond agreement to help fund its $2.7 billion acquisition of ZS Pharma Inc. on Wednesday, one of two pharmaceutical companies to price issuances of...To view the full article, register now.
Already a subscriber? Click here to view full article